Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists: A meta-analysis

OBJECTIVE: The purpose of this study was to assess the efficacy and hypoglycemic risk of sitagliptin versus that of GLP-1 receptor agonists in the management of obese/overweight patients with T2DM. METHODS: EMBASE, PubMed, Cochrane Library, and ClinicalTrials.gov were searched; randomized controlled...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Dai, Danping, Mao, Yiyang, Jin, Haiying, Zhang, Wei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2019
Gaiak:
4200
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739021/
https://ncbi.nlm.nih.gov/pubmed/31490412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017081
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak